By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.

Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.

The Trump administration will end a Medicare Part D subsidy program after 2026. Insurers have gained enough experience to price plans accurately without this support. CMS…

The subsidies are set to end a year ahead of schedule

Millions could face steeper monthly costs

CMS said it will soon no longer provide Medicare Part D, or federal subsidies meant to keep premiums stable for prescription drug plans.